Bill Miller - Miller Value Partners,
Period:    Q1 2026
Portfolio date:    31 Mar 2026
No. of stocks:    55
Portfolio value:    $383,178,520
Holdings Activity Buys Sells    History
Holding/activity history for  Ziopharm Oncology Inc (WEK)
Period Shares % of Portfolio Activity % Change to Portfolio Reported Price Value Filing
2021   Q3 0 0.00 Sell 100.00% 0.65 SEC
2021   Q2 10,317,698 0.65 Reduce 12.82% 0.14 $2.64 $27,238,000 SEC
2021   Q1 11,834,667 1.10 Reduce 5.07% 0.05 $3.60 $42,605,000 SEC
2020   Q4 12,466,248 0.96 Add 0.65% <0.01 $2.52 $31,415,000 SEC
2020   Q3 12,385,586 1.12 Reduce 1.86% 0.03 $2.52 $31,211,000 SEC
2020   Q2 12,619,730 1.84 Reduce 1.85% 0.04 $3.28 $41,393,000 SEC
2020   Q1 12,857,035 2.03 Add 0.96% 0.02 $2.45 $31,500,000 SEC
2019   Q4 12,734,235 2.16 Reduce 1.92% 0.04 $4.72 $60,106,000 SEC
2019   Q3 12,983,146 2.26 Add 40.52% 0.65 $4.28 $55,568,000 SEC
2019   Q2 9,239,150 2.04 $5.83 $53,864,000 SEC
2019   Q1 9,239,150 1.42 Reduce 0.28% <0.01 $3.85 $35,570,000 SEC
2018   Q4 9,264,700 0.76 Add 92.31% 0.36 $1.79 $16,617,000 SEC
2018   Q3 4,817,546 0.51 Reduce 2.02% 0.01 $3.20 $15,416,000 SEC
2018   Q2 4,916,671 0.60 Reduce 2.41% 0.02 $3.02 $14,848,000 SEC
2018   Q1 5,037,946 0.89 Reduce 0.91% <0.01 $3.92 $19,749,000 SEC
2017   Q4 5,084,246 0.98 Add 4.65% 0.04 $4.14 $21,049,000 SEC
2017   Q3 4,858,356 1.41 Reduce 1.38% 0.02 $6.14 $29,830,000 SEC
2017   Q2 4,926,456 1.36 Add 0.02% <0.01 $6.22 $30,643,000 SEC
2017   Q1 4,925,321 1.78 Add 0.50% <0.01 $6.34 $31,227,000 SEC
2016   Q4 4,900,721 1.56 Reduce 2.10% 0.03 $5.35 $26,219,000 SEC
2016   Q3 5,005,921 1.21 $5.63 $28,184,000 SEC
2016   Q2 5,005,921 1.92 Reduce 8.46% 0.18 $5.49 $27,483,000 SEC
2016   Q1 5,468,521 2.15 Add 14.07% 0.27 $7.42 $40,577,000 SEC
2015   Q4 4,793,896 1.60 Add 21.25% 0.28 $8.31 $39,838,000 SEC
2015   Q3 3,953,597 1.06 Add 13.69% 0.13 $9.01 $35,622,000 SEC
2015   Q2 3,477,547 1.71 Add 15.92% 0.23 $12.00 $41,731,000 SEC
2015   Q1 3,000,000 1.32 Buy 1.32 $10.77 $32,310,000 SEC